SUMO1 and liver cancer: Additional clinical evidence highlights a positive association between SUMO1 and phosphorylated p65, suggesting that SUMO1-mediated p65 SUMOylation and p65 phosphorylation at S276 jointly enhance the vitality and invasiveness of liver cancer cells, consequently reducing apoptosis (Jiang et al., 2024).